Drug Topics
OCTOBER 16, 2023
Lisa Faast, CEO and Owner of DiversifyRx, discusses ways that pharmacists can prepare their business for the cash crunch that is set to happen in the first several months of next year.
STAT
OCTOBER 16, 2023
If you’ve been following the mystery of long Covid since it emerged in 2020, you’ll recall interferons and serotonin have been clues from the start as combatants in the body’s prolonged battles against the virus. Theories about why symptoms persist long after the acute infection has cleared often point to two suspects: viral reservoirs where SARS-CoV-2 lingers and inflammation sparked by the infection that doesn’t subside.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
OCTOBER 16, 2023
As the coronavirus outbreak has shifted to the endemic phase, drugmakers have warned of a drop in demand for COVID-19 products, with the impact coming into focus during the fall vaccination season. | Pfizer has slashed its 2023 revenue projection by $9 billion because of declining demand for COVID products. The company now expects sales to reach between $58 billion and $61 billion, down from a prior range of $67 billion to $70 billion.
STAT
OCTOBER 16, 2023
Hospitals are frustrated with a nationwide nursing shortage that’s only gotten worse since the pandemic. In 2022, the American Hospital Association quoted an estimate that half a million nurses would leave the field by the end of that year, bringing the total shortage to 1.1 million. At the same time, National Nurses United insists there isn’t a nurse shortage at all.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Pharma
OCTOBER 16, 2023
Up until this point, immune checkpoint inhibitors have been allowed to treat early-stage non-small cell lung cancer (NSCLC) either before or after surgery. | Thanks to a new FDA approval for Merck's Keytruda, a continuous immunotherapy regimen around surgery is now available for patients with early-stage non-small cell lung cancer. The drug's label already includes an overall survival win from a key trial.
STAT
OCTOBER 16, 2023
The Food and Drug Administration is following through on its promise to regulate more health software tools, starting with a public reprimand of Johnson & Johnson’s heart pump company, Abiomed. Abiomed, which was bought by Johnson & Johnson late last year for $16.6 billion, sells devices for heart failure patients as well as patient monitoring software.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
OCTOBER 16, 2023
WASHINGTON — The White House is about to feel what it’s like to go up against the world’s most powerful tobacco companies. On Friday, the Food and Drug Administration requested White House clearance on a policy that would ultimately ban menthol cigarettes. The tobacco industry has already spent the last few months doing everything it can to drum up opposition, from drafting letters for members of Congress to rallying freedom-focused smokers, according to a review of advertis
Pharmacy Times
OCTOBER 16, 2023
In clinical trials, nivolumab (Opdivo) demonstrated a statistically significant improvement in recurrence-free survival compared to placebo in eligible patients with stages IIB, IIC, III, and stage IV completely resected melanoma.
Drug Topics
OCTOBER 16, 2023
Britney Beck, founder and chief people strategist at Hi-Wire HR Consulting, discusses how pharmacists can navigate the current challenges in the labor market.
STAT
OCTOBER 16, 2023
Steroids were once the only treatment option for some chronic conditions. Today, many other treatments exist, but doctors often stick with the tried-and-true steroids. There are good reasons for this: They are low-cost and readily approved by insurance companies. But while generally safe for short-term use, long-term steroids pose significant dangers.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
OCTOBER 16, 2023
A subcutaneous injection of ocrelizumab was markedly effective at suppressing brain lesions in patients with multiple sclerosis, according to data from a phase 3 trial.
Fierce Healthcare
OCTOBER 16, 2023
A research brief out of think tank Urban Institute evaluates the prospect of reducing Medicare spending by reining in excessive post-acute care rates. | New research shows that MedPAC's previous proposal for a unified payment structure for post-acute care could save Medicare billions.
STAT
OCTOBER 16, 2023
In the latest tussle over the cost of medicines, Teva Pharmaceuticals has filed a lawsuit alleging that a new Colorado program aimed at making epinephrine auto-injectors more affordable violates its constitutional rights. The lawsuit was filed in response to a state law that was passed in August and requires health insurers that provide coverage for these injectors to cap out-of-pocket costs to $60 for a package of two injectors.
Fierce Healthcare
OCTOBER 16, 2023
The National Community Pharmacists Association (NCPA) has launched the latest salvo in its battle with pharmacy benefit managers over controversial fees. | The National Community Pharmacists Association has launched the latest salvo in its battle with pharmacy benefit managers over controversial fees.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Drug Store News
OCTOBER 16, 2023
Rite Aid has received a commitment for $3.45 billion in new financing; names Jeffrey Stein as CEO, succeeding Elizabeth Burr, who has served as interim CEO since January 2023.
STAT
OCTOBER 16, 2023
People with obesity often go underrepresented in drug development trials, a critical gap that researchers say leaves drugmakers and doctors unsure of efficacy or risks in that patient population. “Patients and providers are not aware of how some drugs may act differently in people with obesity,” said Christina Chow, the head of research at Emerald Lake Safety, an institution that conducts independent research to make pharmaceuticals safer.
Pharmacy Times
OCTOBER 16, 2023
Investigators created a model to predict asthma exacerbations that can be integrated in WhatsApp chatbot and relies on self-reported data.
The FDA Law Blog
OCTOBER 16, 2023
By Gail H. Javitt & Steven J. Gonzalez — The Wall Street Journal (WSJ) recently published a series of articles as part of its special report “What’s Ahead for Artificial Intelligence.” Three of these articles focus on medical applications of Artificial Intelligence and Machine Learning (AI/ML) and explore FDA’s role in regulating such products. The first article—“Is the Eye the Window to Alzheimer’s?
Fierce Healthcare
OCTOBER 16, 2023
California Gov. Gavin Newsom signed into law Friday a bill that raises the minimum wage for healthcare workers to $25 per hour across the state over the next several years. | The law is estimated to bring more than $10,000 per year in wage increases for about 450,000 of the Golden State’s low-wage healthcare workers. It requires provider organizations to incrementally raise minimum wages at different rates depending on their size and type.
Pharmacy Times
OCTOBER 16, 2023
AI systems can detect minute anomalies often missed by the human eye, reducing false negatives.
STAT
OCTOBER 16, 2023
CARLSBAD, Calif. — Biotech CEOs leading cell and gene therapy companies spoke frankly at a conference here last week about the tough choices they’re making to preserve limited cash amid the industry’s ongoing slowdown. The company leaders said that they’ve felt added pressure to use smaller teams to work quickly on fewer projects, and at times to partner with outside firms that have specific manufacturing and research expertise.
Fierce Healthcare
OCTOBER 16, 2023
There's another shake-up at the top for CVS Health, the retail health giant announced Monday. | There's another shake-up at the top for CVS Health, the retail health giant announced Monday.
Pharmacy Times
OCTOBER 16, 2023
Maintaining a strict work-life balance, setting boundaries, and trusting instincts can help technicians manage a challenging workplace.
Drug Store News
OCTOBER 16, 2023
Thomas Cowhey, senior vice president of corporate finance, has been appointed interim CFO, while CEO of Oak Street Health Mike Pykosz has been named interim president of Health Services.
Pharmacy Times
OCTOBER 16, 2023
With Halloween just around the corner, now is the perfect time to discuss how medicine was, and still can be, sweet.
Fierce Pharma
OCTOBER 16, 2023
Bristol Myers Squibb’s star Opdivo now can lay claim to an earlier melanoma stage with a new approval that “reinforces the company’s legacy” in treating the cancer type, it said. | Bristol Myers Squibb's Opdivo can now treat completely resected stage 2B or 2C melanoma, adding to its existing approvals in stages 3 and 4 tumors and setting up an expanded market battle with Merck & Co.'s star Keytruda.
The Checkup by Singlecare
OCTOBER 16, 2023
Have you ever had an accident where you hit your ankle on a sharp corner and it starts to swell? Or maybe you’re looking at your phone while lying down, and you drop it smack onto your forehead? Swelling, also known as edema, is your body’s response to injury, illness, or some other outside stimuli. Depending on its severity, it can last days to weeks and can cause pain and discomfort.
STAT
OCTOBER 16, 2023
Good morning, everyone, and welcome to another working week. We hope the weekend respite was sufficiently relaxing and invigorating, because that oh-so-familiar routine of online calls and deadlines has returned. After all, the world — such as it is — continues to spin. And to nudge it in a much-needed better direction, we are quaffing cups of stimulation.
The Checkup by Singlecare
OCTOBER 16, 2023
If you or a loved one have recently been injured or diagnosed with an illness that impedes your daily life, you might wonder: What medical conditions automatically qualify you for disability? What criteria do you need to meet to get federal disability benefits? Where do you go to start the process? You can begin with the Social Security Administration (SSA).
STAT
OCTOBER 16, 2023
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning! Today, cell and gene therapy executives describe how they’re handling their sector’s contraction, we talk about how regulators are cracking down on clinical decision support software, and we look at some impressive BTK data in multiple sclerosis from Roche.
Pharmacy Times
OCTOBER 16, 2023
Rite Aid filed for bankruptcy protection and said it plans to close several hundred retail stores.
Outsourcing Pharma
OCTOBER 16, 2023
In our first podcast interview of 2023, BioPharma Reporter spoke with Dr Sarah Bateup, therapy lead at Clerkenwell Health, about the potential of psychedelic medicine and her work within the psychedelic therapy training space.
European Pharmaceutical Review
OCTOBER 16, 2023
Lonza is planning to build a commercial-scale aseptic current good manufacturing practice (cGMP) filling line at its site in Stein, Switzerland. The new filling line will facilitate the aseptic filling of highly-potent antibody drug conjugates (ADCs) and lyophilisation under containment. The added capabilities will increase Lonza’s capacity to support clinical and commercial supply of bioconjugates.
Fierce Pharma
OCTOBER 16, 2023
Dorothy Gemmell, Chief Commercial Officer at GoodRx, discusses two powerful and practical opportunities in pharma marketing today: personalization and partnerships. | Dorothy Gemmell, Chief Commercial Officer at GoodRx, discusses two powerful and practical opportunities in pharma marketing today: personalization and partnerships.
Expert insights. Personalized for you.
227 
Let's personalize your content